Mesenchymal stem cell
Top PDF Mesenchymal stem cell:
A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods
... The mesenchymal stem cell (MSC) is being broadly studied in clinical ...of cell replacement and differentiation as a therapeutic mechanism of action, evidence is mounting that the secretions ...
14
Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model
... epithelial mesenchymal transition; ESRD, end- stage renal disease; GFP, green fluorescence protein; H&E, haematoxylin and eosin; IHC, immunohistochemistry; MSC, mesenchymal stem cell(s); ...
11
TítuloUmbilical cord as a mesenchymal stem cell source for treating joint pathologies
... Figure 1 Characterization of the mesenchymal stem cell population from human umbilical cord stroma. A: Flow cytometry of the principal mesenchymal stem cell (MSC) markers. In ...
8
TítuloEffect of age on pro inflammatory miRNAs contained in mesenchymal stem cell derived extracellular vesicles
... Figure 4. Age-related study of pro-inflammatory factors in mesenchymal stem cell-derived extracellular vesicles. (A) miR-146a, (B) miR-155, (C) miR-132, (D) miR-335 and (E) miR-21 expression using ...
11
TítuloQuantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synovial membranes
... demonstrate that the synovial tissue of healthy donors contains MSC markers before any active articular inflammatory process occurs. We also note that during degenerative inflammatory processes a number of our OA cases ...
12
Mesenchymal Stem Cell Culture on Composite Hydrogels of Hydroxyapatite Nanoparticles and Photo-Crosslinking Chitosan
... hydrogels. Mesenchymal stem cells, from rat bone marrow, were seeded onto the hydrogels and cultured for 4, 10 and 16 days, under osteogenic and non-osteogenic ...Through cell proliferation and ...
13
TítuloInfluence of mesenchymal stem cell derived extracellular vesicles in vitro and their role in ageing
... expression both at the proteomic and genetic levels in relationship with age. A decrease in the expression of this gene was observed in old MSC cultured with young MSC-derived EVs, while an increase was found in young ...
12
TítuloChondrogenic potential of subpopulations of cells expressing mesenchymal stem cell markers derived from human synovial membranes
... various cell types [Jo et ...T cell activation and adhesion of lymphocytes to the endothelium [Majore et ...vascular cell adhesion molecule (VCAM), also called CD106, is expressed on activated ...
16
TítuloGenerating Rho 0 cells using mesenchymal stem cell lines
... in cell culture and differentiate into the standard osteogenic, adipogenic and chondrogenic lineages in appropriate media ...tumor cell lines with hMSCs from bone ...
23
Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials
... availability, cell-based therapies offer a new all-encompassing ...of mesenchymal stem cells (MSCs) have been obtained by several preclinical studies of various neurodegenerative ...of cell ...
9
Therapeutic Effect of Human Adipose Tissue-Derived Mesenchymal Stem Cells in Experimental Corneal Failure Due to Limbal Stem Cell Niche Damage
... limbal stem cell marker, in the ocular surface of the partial and total limbal stem cell deficiency (LSCD) models at the end of the follow-up ...tissue-derived mesenchymal stem ...
24
Strength and stiffness of repaired tendons
... years, mesenchymal stem cell therapy has emerged as a promising ...technique. Mesenchymal stem cells are of stromal origin and may differentiate into a variety of ...multipotent ...
6
TítuloEffect of aging on behaviour of mesenchymal stem cells
... in mesenchymal stem ...young mesenchymal stem cells (MSCs) is influenced by their autophagy capacity to regulate the good levels of oncogenic factors like p53 and inflammatory signals like ...
14
Clulas estromales atpicas como trampa diagnstica en las lesiones del aparato genital femenino con presentacin de casos excepcionales
... primitive stem cell population present in the thin myxoid subepithelial layer of lower female genital tract, representing some mesenchymal cells which have the ability to differentiate towards either ...
5
Characterization of Adult Stem/Progenitor Cell Populations From Bone Marrow in a Three-Dimensional Collagen Gel Culture System.
... trabecular matrix, lined by osteoblast-like cells, with numerous marrow spaces highly vascularized. This bone tissue seems to have intramembranous origin because no trace of cartilage can be found, such as hypertrophic ...
12
Stem Cell Biobanks for Research
... National Stem Cell Bank (BNLC - ...of stem cell lines, both pluripotent (embryonic and iPSCs) and ...to cell pro- duction and ...adult stem cell ...dedicated stem ...
16
Functionalizing artificial nerve guides to promote regeneration and recovery after peripheral nerve injuries
... Schwann cell-transplanted animals offer the best results, with better functional recovery, higher number of myelinated fibers and a complete success of regenerated animals ...hand, Mesenchymal-stem ...
197
Adipose derived mesenchymal stem cells : are they a good therapeutic strategy for osteoarthritis? / Elena Damiá, Deborah Chicharro, Sergio López, Belén Cuervo, Mónica Rubio, Joaquín Sopena, José Manuel Vilar and José María Carrillo
... [17]. Mesenchymal stem cells (MSCs) are considered to be a promising candidate for cartilage regeneration, due to their ability to differentiate towards cartilage and bone cells and secrete trophic factors ...
14
Estudio Cuantitativo del crecimiento de cultivo de Células Madre mesenquimales derivadas de tejido adiposo
... (MSC-mesenchymal stem cells) son aquellas células que originalmente se consideraba que poseían la habilidad de diferenciarse en tejidos derivados del mesodermo: musculo esquelético, hueso, tendones, ...
38
Busulfan based myeloablative conditioning regimens for haploidentical transplantation in high risk acute leukemias and myelodysplastic syndromes
... The study population comprised mainly AL patients (AML 72%, acute lymphocytic leukemia 12%), with a median age of 42 years, who were in morphologic CR at the time of HAPLO- MAC (85%) but with persistent MRD+ (37%) and ...
27